The NGS sample preparation market is projected to reach $7.1 billion by 2030, growing at 14.5% CAGR, driven by automation, high-throughput workflows, and diagnostic sequencing demand.
Read More
Otic drugs market to reach $2.59 billion by 2030 at 7.5% cagr, driven by rising prevalence rate of ear infections and hearing-related disorders.
Read More
Otc dry eye drops market to reach $5.33 billion by 2030 at 7.0% cagr, driven by increasing screen exposure and growing digital eye strain.
Read More
The Next Generation Sequencing (NGS) in agrigenomics market size is expected to reach $4.48 billion in 2030 at 12.1%, driven by advanced sequencing technologies
Read More
Otc drug and dietary supplement market to reach $497.84 billion by 2030 at 7.2% cagr, driven by rising pharma research and development expenditure globally.
Read More
Global Next Generation Immunotherapies market size is expected to reach $262.82 billion by 2030 at 11.8%, rising cancer prevalence driving growth in the market
Read More
Osteoporosis drugs market to reach $16.21 billion by 2030 at 4.3% cagr, driven by surging prevalence of osteoporosis among aging populations worldwide.
Read More
The Next Generation Cancer Diagnostics market size is expected to reach $26.44 billion in 2030 at 12.9%, driven by rising focus on precision oncology.
Read More
Osteogenesis imperfecta treatment market to reach $1.16 billion by 2030 at 4.3% cagr, driven by increasing prevalence of osteogenesis imperfecta due to improved genetic diagnosis.
Read More
Global Neuropathic Pain market size is expected to reach $6.78 billion by 2030 at 35.8%, segmented as by medications, anticonvulsants, antidepressants, opioids, topical treatments, non-steroidal anti-inflammatory drugs (nsaids)
Read More